Evidence map›Paper›PMID 33456358›Full record

ArticleInternational journal of medical sciences2021

Intraocular pressure-lowering effect of

Chi-Ting Horng, Ya-Lan Yang, Chin-Chu Chen, Yu-Syuan Huang, Chun Chen, Fu-An Chen

Open access · goldAbstract read
In one paragraph

Article in International journal of medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Evaluation of the Impact ofInternational journal of medical sciences · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Preventative Effects ofNutrients · 2023
    Article
  10. Evaluation of trabecular meshwork-specific promotersInternational journal of ophthalmology · 2023
    Article
  11. Amelioration of Cyclosporine A-Induced Acute Nephrotoxicity byInternational journal of molecular sciences · 2023
    Article
  12. Lowering the Intraocular Pressure in Rats and Rabbits byMolecules (Basel, Switzerland) · 2022
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chi-Ting HorngDepartment of Ophthalmology, Fooyin University Hospital, Pingtung, Taiwan.
Ya-Lan YangDepartment of Pharmacy and Master Program, Tajen University, Pingtung, Taiwan.
Chin-Chu ChenGrape King Bio Ltd, Zhong-Li Dist., Taoyuan City, Taiwan.
Yu-Syuan HuangDepartment of Pharmacy and Master Program, Tajen University, Pingtung, Taiwan.
Chun ChenDepartment of Pharmacy and Master Program, Tajen University, Pingtung, Taiwan.
Fu-An ChenDepartment of Pharmacy and Master Program, Tajen University, Pingtung, Taiwan.
Tajen University · TWGrape King (Taiwan) · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glaucoma is a leading cause of irreversible blindness worldwide. This study evaluates the reduction of intraocular pressure (IOP) induced by

Indexed as

Administration, OralAnimalsAntioxidantsBetamethasoneBiological ProductsCordycepsDisease Models, AnimalGlaucomaHumansIntraocular PressureMaleMyceliumRatsAntioxidantsBetamethasoneBiological ProductsAntioxidantCordyceps cicadae myceliaGlaucomaIntraocular pressure

Identifiers

PMID33456358
PMCPMC7807192
OpenAlexW3119954774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.